Not a Lexis Advance subscriber? Try it out for free.

Plexxikon Inc. v. Novartis Pharms. Corp.

United States District Court for the Northern District of California

December 7, 2017, Decided; December 7, 2017, Filed

Case No.17-cv-04405-HSG

Opinion

ORDER DENYING DEFENDANT'S VENUE-RELATED MOTIONS

Re: Dkt. Nos. 33, 37

Pending before the Court are Defendant Novartis Pharmaceuticals Corporation's venue-related motions: a motion to dismiss (or, in the alternative, transfer) under 28 U.S.C. § 1406, Dkt. No. 33, and a motion to transfer under 28 U.S.C. § 1404, Dkt. No. 37. For the reasons set forth below, Defendant's motions are DENIED.

I. BACKGROUND

On November 2, 2017, Plaintiff Plexxikon Inc. filed an amended complaint against [*2]  Defendant alleging direct patent infringement, Dkt. No. 40 (First Amended Complaint or "FAC") ¶¶ 41-50, as well as inducement of infringement and contributory infringement, id. ¶¶ 51-61. Plaintiff filed the original complaint on August 3, 2017. Dkt. No. 1.

On October 12, 2017, Defendant filed a motion to dismiss (or, in the alternative, transfer) under section 1406. Dkt. No. 33. Plaintiff filed its opposition on October 26, 2017, Dkt. No. 35, and Defendant replied on November 2, 2017, Dkt. No. 36. Also on November 2, Defendant filed a motion to transfer the case under section 1404. Dkt. No. 37. Plaintiff filed its opposition on November 16, 2017, Dkt. No. 48, and Defendant replied on November 24, 2017, Dkt. No. 50.

On November 3, 2017, the Court consolidated these venue-related motions to be heard on January 25, 2018. Dkt. No. 41. At a case management conference on November 28, 2017, the Court advanced the hearing on these motions to December 12, 2017. See Dkt. Nos. 41, 51. The Court finds this matter appropriate for disposition without oral argument and deems the matter submitted. See Civil L.R. 7-1(b).

II. DEFENDANT'S MOTION TO DISMISS OR TRANSFER UNDER SECTION 1406

Read The Full CaseNot a Lexis Advance subscriber? Try it out for free.

Full case includes Shepard's, Headnotes, Legal Analytics from Lex Machina, and more.

2017 U.S. Dist. LEXIS 201984 *

PLEXXIKON INC., Plaintiff, v. NOVARTIS PHARMACEUTICALS CORPORATION, Defendant.

Subsequent History: Later proceeding at Plexxikon Inc. v. Novartis Pharms. Corp., 2019 U.S. Dist. LEXIS 16695 (N.D. Cal., Feb. 1, 2019)

Motion granted by Plexxikon Inc. v. Novartis Pharms. Corp., 2019 U.S. Dist. LEXIS 48380 (N.D. Cal., Mar. 22, 2019)

Request granted Plexxikon Inc. v. Novartis Pharms. Corp., 2019 U.S. Dist. LEXIS 230438 (N.D. Cal., May 3, 2019)

Motion granted by Plexxikon Inc. v. Novartis Pharms. Corp., 2019 U.S. Dist. LEXIS 189834 (N.D. Cal., Oct. 25, 2019)

Motion denied by Plexxikon Inc. v. Novartis Pharms. Corp., 2020 U.S. Dist. LEXIS 7784 (N.D. Cal., Jan. 16, 2020)

Motion granted by, in part, Motion denied by, in part Plexxikon Inc. v. Novartis Pharms. Corp., 2020 U.S. Dist. LEXIS 44014 (N.D. Cal., Mar. 13, 2020)

Motion granted by, in part, Motion denied by Plexxikon Inc. v. Novartis Pharms. Corp., 2020 U.S. Dist. LEXIS 48769 (N.D. Cal., Mar. 20, 2020)

Motion denied by Plexxikon Inc. v. Novartis Pharm. Corp., 2020 U.S. Dist. LEXIS 51894 (N.D. Cal., Mar. 25, 2020)

Motion granted by Plexxikon Inc. v. Novartis Pharms. Corp., 2020 U.S. Dist. LEXIS 63506 (N.D. Cal., Apr. 10, 2020)

Motion denied by Plexxikon Inc. v. Novartis Pharms. Corp., 2020 U.S. Dist. LEXIS 81665 (N.D. Cal., May 8, 2020)

Motion granted by, in part, Motion denied by, in part Plexxikon Inc. v. Novartis Pharms. Corp., 2020 U.S. Dist. LEXIS 91618 (N.D. Cal., May 26, 2020)

CORE TERMS

venue, infringement, patent, convenience, deference, inconvenience, regular